Aguggini, S.

Allevi, G.

Angeli, A.

Berruti, A.

Bonardi, S.

Bottini, A.

Dogliotti, L.

Dovio, A.

Generali, D.

Milani, M.

Tampellini, M.

Tedoldi, S.

Tucci, M.

Scientific Open-access Literature Archive and Repository

THE CIRCADIAN RHYTHM OF BIOCHEMICAL MARKERS OF BONE RESORPTIONIS NORMALLY SYNCHRONIZED IN BREAST CANCER PATIENTS WITH BONE LYTIC METASTASES INDEPENDENTLY OF TUMOR LOADA. Dovio1, D. Generali2, A. Berruti1, M. Tampellini1, S. Tedoldi2, S. Bonardi2, M. Tucci1, G. Allevi2, S. Aguggini2, M. Milani2, A. Bottini2, L. Dogliotti1, A. Angeli11 Department of Clinical and Biological Sciences, Orbassano, University of Turin, Turin, Italy2 Azienda Ospedaliera Istituti Ospitalieri, Breast Cancer Unit, Cremona, Italy Bone metastases are common devastating events in the natural history of malignant diseases. Their de-velopment results in a profound disruption of local bone remodelling processes. Physiological boneturnover has a circadian rhythm. No data are available on the circadian pattern of bone turnover markersin patients with bone metastases.Twenty post-menopausal women with breast cancer (BC) at first relapse, at least one bone metastasisand no concomitant chemotherapy/endocrine therapy were consecutively recruited. Twenty healthywomen served as controls. Throughout a 24-h period, urine and blood samples were collected at 2 to 4-hintervals. Serum osteocalcin (OC), total and bone-alkaline phosphatase (tALP and bALP, respectively)and C-terminal telopeptide of type I collagen (CTX), and urinary NTX and deoxypyridinoline (DPD) weremeasured together with serum PTH and serum and urinary calcium and phosphorus. Temporal variationsof measured analytes were assessed by ANOVA and the COSINOR model. At 08:00, patients had higherlevels of bone resorption indices (NTX, CTX and DPD) than controls (p<0.0001). Total and bone-specificALP, but not OC, was higher in patients than controls (p<0.001). PTH, serum and urinary calcium and uri-nary phosphorus did not differ between groups, whereas serum phosphorus was higher in controls(p<0.0001). In both patients and controls a circadian rhythm was evident for CTX and DPD values, withan acrophase respectively in the night (patients 02:40; controls 05:21) and in the morning (patients 09:30;controls 08:22). When considering absolute values, a circadian rhythm in NTX, osteocalcin and PTH wasapparent only in controls; however, it was detected also in patients when considering percent changesfrom MESOR. Also serum phosphorus showed a circadian rhythm, while no rhythm was detected fortALP, bALP, serum and urinary calcim. In patients the rhythmicities were normally synchronized, andrhythmic parameters were independent of tumor load in the skeleton and age. To the best of our knowl-edge, this is the first study to yield information on the maintenance of the temporal program of boneturnover in bone-metastatic cancer patients. Research is needed to assess whether administration of bis-phosphonates in the night time before the peak has a different outcome with respect to the current adm-nistration in the morning.210 Clinical Cases in Mineral and Bone Metabolism 2005; 2(3): 185-252BSTR CT (V Congresso CCMBM)  18/11/2005  15.59  Pagina 210FOR REVIEW ONLY© CIC EDIZIONI INTERNAZIONALI

The circadian rhythm of biochemical makers of bone resorption is normally synchronized in breast cancer patients with bone metastases indipendently of tumor load

http://eprints.bice.rm.cnr.it/8968/1/article.pdf

The circadian rhythm of biochemical makers of bone resorption is normally synchronized in breast cancer patients with bone metastases indipendently of tumor load

Abstract

Similar works

Full text

Available Versions

Scientific Open-access Literature Archive and Repository